www.usatoday.com

www.usatoday.com
Share

www.usatoday.com

 •  January 14

U.S. health insurer UnitedHealth Group said it will buy a primary and urgent care unit of DaVita to bolster its primary and urgent care services. Fred Katayama reports. Video provided by Reuters Newslook The health care industry's fever for consolidation has shot up with two major deals closing out 2017, but the big question is whether consumers...

www.usatoday.com

 •  January 2

The Food and Drug Administration takes an average of 57 days to remove contaminated food from the shelves, according to a report by federal investigators. Veuer's Elizabeth Keatinge (@elizkeatinge) has more. Buzz60 We have formed a new team to focus on the complex recalls examined by the IG: Opposing view Americans depend on the U.S. Food and Drug...

www.usatoday.com

 •  October 31, 2017

Eighteen pharmaceutical companies conspired to fix the prices of certain critical treatments for patients suffering from conditions such as diabetes, hypertension, high blood pressure and rheumatoid arthritis, according to new allegations by the top law enforcement officials in 45 states. Companies ranging from EpiPen maker Mylan Pharmaceuticals to...

www.usatoday.com

 •  October 23, 2017

USA TODAY WASHINGTON — The Food and Drug Administration's new chief says he doesn't want to repeat the mistakes made when he was at the agency in the 2000s and the government failed to regulate opioids more. “We didn’t get ahead of it. Nobody got ahead of it,” physician Scott Gottlieb said last week at a National Academy of Medicine conference....

www.usatoday.com

 •  October 16, 2017

Ensuring patient access to medicines that are revolutionizing how we fight disease is critically important. Equally so is understanding when additional safeguards are required to ensure a medicine’s benefits outweigh its risks. In such cases, the Food and Drug Administration may require the biopharmaceutical company that manufactures the medicine...

www.usatoday.com

 •  September 27, 2017

NorthJersey.com Pharmaceutical companies around the country have begun developing a range of non-addictive treatments in response to the country's deadly heroin and opiate crisis, but executives told a presidential panel that they face financial, regulatory and insurance obstacles that could delay meaningful progress toward curbing the abuse. In a...

www.usatoday.com

 •  September 27, 2017

“The cost of medicine in this country is outrageous,” President Trump said at a rally in Louisville, Ky., two months after his inauguration. He went on about how identical pills have vastly lower price tags in Europe. “You know why?” the president asked, before spreading his hands wide. “Campaign contributions, who knows. But somebody is getting...

www.usatoday.com

 •  September 26, 2017

Newslook The U.S. Food and Drug Administration is warning of possible "critical shortages" of key pharmaceuticals after Hurricane Maria brought Puerto Rico's drug manufacturing industry to a standstill. The FDA said late Monday that it is taking active measures to help redirect production and preserve existing treatments to avoid a ballooning...

www.usatoday.com

 •  September 19, 2017

ALBANY, N.Y. — Attorneys general across the country are demanding information from pharmaceutical companies in an ongoing investigation into prescription drug abuse. A bipartisan coalition of 41 attorneys general said Tuesday they have jointly filed subpoenas to major opioid distributors and manufacturers as they investigate how prescription drugs...

www.usatoday.com

 •  September 15, 2017

Pharmaceutical giant Bayer won swift U.S. regulatory approval to sell a drug that could help treat up to one in five lymphoma patients. The Food and Drug Administration has authorized the German drug maker to begin selling Aliqopa, which will treat adult patients who have relapsed after at least two previous therapies for follicular B-cell...